The Pennsylvania State University, United States
As a passionate leader and driver of scientific research, my goal is to bring a higher level of innovation, collaboration and translation to our communities and our world. Drawing on the wide breadth and depth of my career trajectory, my hopes are to help change our world for the better.
"Penn State is at an inflection point, as is the nation and the world. I am excited to have the opportunity to be a fierce advocate for Penn State Research during a time of immense change. Our research mission is urgent and vital: knowledge creation, dissemination and implementation will be key determinants of human wellbeing in the rest of this century." - Andrew
As Senior Vice President for Research at Penn State, I oversee the research of twelve academic colleges, seven interdisciplinary research institutes, the Applied Research Lab, which is a university affiliated research center for the Navy, and offices for sponsored programs, research protections, industry partnerships, technology transfer, innovation, economic development, and commercialization.
Some of my various areas of expertise:
Research: Evolutionary microbiology. I have worked on Myxoma Virus in rabbits (virulence), Marek’s disease in poultry (vaccine resistance), malaria in mice (virulence & vaccine and drug resistance) and vancomycin-resistant Enterococcus (bacterial resistance in hospitals), with a little cancer on the side.
Teaching: I have taught zoology, evolutionary biology, microbiology, parasitology, ecology and statistics, and, by far the most challenging, non-scientists to be better consumers of science (2010-2018).
Leadership experience: Director, Penn State's Center for Infectious Disease Dynamics (2010-2017); Director, Huck Institutes of the Life Science, Penn State (2017-2023), a position which reports to the Senior Vice President for Research at Penn State.
I have had sabbaticals at the Wissenschaftskolleg zu Berlin (2007-8) and the ETH Zurich (2018-2019), and was an Adjunct Professor at the University of Tromso, Norway (1992-1997).
Disclosure information not submitted.
Oral Administration of a Nano-Enabled Anti-antibiotic Prevents Vancomycin Resistance in the GI Tract
Thursday, October 24, 2024
8:45 AM – 9:00 AM EST